Agilon Health Capital Surpluse Over Time
AGL Stock | USD 2.18 0.01 0.46% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Agilon Health Performance and Agilon Health Correlation. Agilon |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 11.951 | Earnings Share (0.76) | Revenue Per Share 13.717 | Quarterly Revenue Growth 0.276 | Return On Assets (0.1) |
The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Capital Surpluse Analysis
Compare agilon health and related stocks such as Ensign Group, Universal Health Services, and Addus HomeCare Capital Surpluse Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENSG | 77.3 M | 77.3 M | 101.4 M | 101.4 M | 114.3 M | 235.1 M | 252.5 M | 266.1 M | 284.4 M | 307.9 M | 338.2 M | 369.8 M | 415.6 M | 477.9 M | 276.2 M |
ADUS | 82.4 M | 82.4 M | 82.8 M | 83.1 M | 84.9 M | 87.1 M | 92.3 M | 96 M | 177.7 M | 359.5 M | 369.5 M | 380 M | 380 M | 437 M | 458.9 M |
EHC | 2.9 B | 2.9 B | 2.9 B | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 2.6 B | 2.4 B | 2.3 B | 2.3 B | 1.7 B | 1.6 B | 2.1 B |
SGRY | 316.3 M | 316.3 M | 316.3 M | 316.3 M | 316.3 M | 316.3 M | 320.5 M | 695.6 M | 673.6 M | 662.7 M | 607.9 M | 1.6 B | 2.5 B | 2.8 B | 3 B |
ACHC | 140.6 M | 140.6 M | 461.8 M | 461.8 M | 847.3 M | 1.6 B | 2.5 B | 2.5 B | 2.5 B | 2.6 B | 2.6 B | 2.6 B | 2.6 B | 3 B | 2 B |
AMED | 363.7 M | 432.4 M | 450.8 M | 467.9 M | 481.8 M | 504.3 M | 537.5 M | 568.8 M | 603.7 M | 645.3 M | 698.3 M | 728.1 M | 755.1 M | 868.3 M | 600.6 M |
MODV | 176.2 M | 176.2 M | 194.4 M | 194.4 M | 261.2 M | 293 M | 302 M | 314 M | 334.7 M | 351.5 M | 421.3 M | 430.4 M | 444.3 M | 510.9 M | 352.3 M |
PNTG | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 74.9 M | 84.7 M | 95.6 M | 99.8 M | 114.7 M | 65.1 M |
HCSG | 100.1 M | 105.7 M | 168.3 M | 168.3 M | 186 M | 199.3 M | 217.7 M | 244.4 M | 259.4 M | 270.6 M | 282.2 M | 294.1 M | 302.3 M | 347.6 M | 241.1 M |
EHAB | 406.9 M | 406.9 M | 406.9 M | 406.9 M | 406.9 M | 406.9 M | 406.9 M | 406.9 M | 406.9 M | 406.9 M | 406.9 M | 406.9 M | 406.9 M | 366.2 M | 325.5 M |
CCM | 8.7 M | 8.7 M | 8.7 M | 8.7 M | 8.7 M | 1.8 B | 1.9 B | 1.9 B | 1.8 B | 1.8 B | 1.8 B | 1.9 B | 1.9 B | 2.2 B | 1.8 B |
NHC | 155 M | 155 M | 155 M | 155 M | 155 M | 209.5 M | 211.5 M | 215.7 M | 219.4 M | 222.8 M | 226.9 M | 232.2 M | 227 M | 261 M | 234.7 M |
USPH | 36.1 M | 36.1 M | 37.5 M | 40.6 M | 45.3 M | 45.3 M | 68.7 M | 73.9 M | 80 M | 87.4 M | 95.6 M | 102.7 M | 102.7 M | 118.1 M | 73.5 M |
agilon health and related stocks such as Ensign Group, Universal Health Services, and Addus HomeCare Capital Surpluse description
My Equities
My Current Equities and Potential Positions
agilon health | AGL |
Classification | Healthcare |
Location | California; U.S.A |
Exchange | New York Stock Exchange |
USD 2.18
Check out Agilon Health Performance and Agilon Health Correlation. For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Agilon Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.